Jan 8 (Reuters) - AVITA Medical's Australia-listed shares sank nearly 19% on Wednesday, set for their worst day in 15 months, after the regenerative medicine firm cut its forecast for the fourth ...

Avita Medical, a regenerative medicine company pitching a spray-on skin to burn patients, says it will miss its revenue forecasts, sending shares sliding by a fifth to just a third of its record $ ...

Avita, which specializes in wound care and skin restoration, anticipates fourth-quarter commercial revenue of approximately $18.4 million. It reflects a 30% year-over-year increase. However ...

Lake Street analyst Brooks O’Neil lowered the firm’s price target on Avita Medical (RCEL) to $14 from $20 and keeps a Buy rating on the shares after the company announced preliminary Q4 ...

Hence, I upgrade it to a "Buy." Avita Medical (NASDAQ:RCEL) is a biotech focused on regenerative skin treatments. Since the last time I covered RCEL the company back in May, it has received ...

There are legacy options you may be more familiar with, like a digital optical or TosLink cable, but the same HDMI cable that you use to connect your OLED, QLED, or LED-powered screen to your ...

The news: Avita Medical shares have tumbled for a second straight session after the medical technology company downgraded its revenue guidance, but Morningstar analysts say the share remains ...

Commercialisation of the Company's regenerative product.

The Infinix InBook Y3 Max packs 512GB of SSD storage. Connectivity options include Wi-Fi 802.11 a/b/g/n/ac and it comes with 4 USB ports (2 x USB 3.0 (Type C), 2 x USB 3.1 Gen 1 (Type C)), HDMI Port, ...

Founded back in 1969 as Samsung Electric Industries, Suwon, South Korea-headquartered Samsung Electronics today makes everything from televisions to semiconductors. It released its first Android ...